 [2005-5-21]卡维地洛药理作用"大揭密" |
| [2005-5-21]头孢菌素另有其作用 |
| [2005-5-21]贯众抗病毒究其根源 |
| [2005-5-21]延缓衰老 探讨药效 |
| [2005-5-21]小儿双清颗粒药理作用研究出显成效 |
| [2005-5-21]降压药研制的新动向 |
| [2005-5-21]辛夷油药效学初探 |
| [2005-5-21]普罗帕酮两对映体间的药动学和药效学相互作用研究 |
| [2005-5-21]老年人的药效学 |
| [2005-5-21]硫代硫酸钠在体内、外辅佐抗癌药药效学初步研究 |
| [2005-5-21]安神颗粒的主要药效学试验 |
| [2005-5-21]甲磺酸去铁胺抗庆大霉素耳毒性作用及机理研究 |
| [2005-5-21]复方烧伤喷雾剂的药效学研究 |
| [2005-5-21]抗菌药物的序贯疗法 |
| [2005-5-21]瓜蒌的现代药理研究 |
| [2005-5-21]平溃散具胃黏膜保护作用 |
| [2005-5-21]芦荟抗衰老机理揭密 |
| [2005-5-21]蟾酥现代药理研究进展 |
| [2005-5-21]实验发现舒肝丸疗效基础 |
| [2005-5-21]内皮素在DR中起重要作用 |
| [2005-5-21]苦参碱多种制剂的药效学研究进展 |
| [2005-5-21]迪力(注射用肌苷冻干粉针)药效学研究综述 |
| [2005-5-21]茚地那韦的药理及临床应用 |
| [2005-5-21]抑肽酶有抗炎作用吗？ |
| [2005-5-21]瘿消颗粒剂的药效学研究 |
| [2005-5-21]升白素治疗白细胞减少症的临床药效学研究 |
| [2005-5-21]通痹止痛颗粒的抗炎镇痛作用 |
| [2005-5-21]实验研究证实：麻黄汤治疗哮喘作用机制 |
| [2005-5-21]紫苏药效研究新发现 |
| [2005-5-21]COX-2抑制剂：化学结构不同 安全特性有异 |
| [2005-5-21]COX-2抑制剂：化学结构不同 安全特性有异 |
| [2005-5-21]铁皮石斛降糖作用机理被证实 |
| [2005-5-21]对NSAIDs安全性的再思考 |
| [2005-5-21]阿伐他汀降低原发性高脂血症病人血尿酸水平 |
| [2005-5-21]利福拉齐治愈大鼠模型艰难梭菌引起的腹泻 |
| [2005-5-21]治疗儿童重度肺炎口服阿莫西林与注射青霉素等效 |
| [2005-5-21]青蒿素要“改行”抗癌 |
| [2005-5-21]“他汀时代”辅酶Q10的应用前景 |
| [2005-5-21]中药化学成分抗内毒素研究现状(一) |
| [2005-5-21]降脂药可延缓阿尔茨海默病的进程 |
| [2005-5-21]Bivalirudin Effective, with Less Bleeding, During Percutaneous Coronary Interven |
| [2005-5-21]中国将成为世界的临床试验基地 |
| [2005-5-21]反义抗癌药GTI-2501即将进入II期临床试验 |
| [2005-5-21]Allos公司放疗增敏剂RSR13三期临床失败 |
| [2005-5-21]AGI-1067用于动脉粥样硬化的Ⅲ期临床 |
| [2005-5-21]Axokine治疗肥胖三期临床试验结果公布 |
| [2005-5-21]抗癌药物临床试验进展 |
| [2005-5-21]Phase II study of irinotecan and ifosfamide in patients with advanced non-small |
| [2005-5-21]U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens |
| [2005-5-21]Randomized clinical trial of an implantable drug delivery system compared with c |
| [2005-5-21]Pharmacology of the ACAT Inhibitor Avasimibe (CI-1011) |
| [2005-5-21]BMS-191095 for Treatment of Acute Myocardial Ischemia |
| [2005-5-21]Endothelin Antagonism with Bosentan: Current Status and Future Perspectives Koh |
| [2005-5-21]Endothelin Antagonism with Bosentan: Current Status and Future Perspectives |
| [2005-5-21]BQ-788, A Selective Endothelin ETB Receptor Antagonist |
| [2005-5-21]The Antiarrhythmic Drug BRL-32872 |
| [2005-5-21]Bucillamine: A Potent Thiol Donor with Multiple Clinical Applications |
| [2005-5-21]The Antiatherogenic Effect of DiNAC: Experimental Findings Supporting Immunomodu |
| [2005-5-21]Nonpeptide Factor Xa Inhibitors:DPC423, A Highly Potent and Orally Bioavailable |
| [2005-5-21]DX-9065a, a Direct Inhibitor of Factor Xa |
| [2005-5-21]Efonidipine Hydrochloride:A Dual Blocker of L- and T-Type Ca2+ Channels |
| [2005-5-21]Protection of the Cardiovascular System by Imidapril, a Versatile Angiotensin-Co |
| [2005-5-21]Dual ACE and NEP Inhibitors:A Review of the Pharmacological Properties of MDL 10 |
| [2005-5-21]The P2Y1 Receptor as a Target for New Antithrombotic Drugs: A Review of the P2Y1 |
| [2005-5-21]Lipoprotein Lipase Activator NO-1886 |
| [2005-5-21]Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodil |
| [2005-5-21]Rosuvastatin: A Highly Effective New HMG-CoA Reductase Inhibitor |
| [2005-5-21]The Low Molecular Weight Heparin, Tinzaparin, in Thrombosis and Beyond |
| [2005-5-21]Role of Tissue Factor Pathway Inhibitor in the Regulation of Tissue Factor-Depen |
| [2005-5-21]Zoniporide: A Potent and Selective Inhibitor of the Human Sodium-Hydrogen Exchan |
| [2005-5-21]Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in Nort |
| [2005-5-21]Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in Nort |
| [2005-5-21]Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in Nort |
| [2005-5-21]治疗高血压的另一种新药——血管肽酶抑制剂 |
| [2005-5-21]高血压治疗新药：eplerenone |
| [2005-5-21]氯吡格雷(波立维)及相关临床试验 |
| [2005-5-21]干扰素是一种天然的抗病毒蛋白质 |
| [2005-5-21]HDL Mimetic Reduces Atherosclerosis in Phase II Study |
| [2005-5-21]西比灵的药理作用介绍 |
| [2005-5-21]腺苷注射液在国内上市 |
